Co-President and Regional Market Director - Greater Boston

Hunter Kass

Vice President

Deborah Dreher

VP of Human Resources

Jessica Hays

Director - Talent

Agata Magalinskaya

Director of Acquisitions

Alex Bisanz

Executive Director - Asset Services

Alexa Sadler

Human Resources

Alison Lauderbach - Ferris

Director - Asset Services

Alyssa Carpenter

Finance and Administration

Amanda Croce

Senior Director of Asset Management

Amy Emmanuel

Steven Hash

Joel Marcus

Jennifer J. Banks

General Counsel

Hallie Kuhn

Lynne Zydowsky

Chief Science Officer and Co-Founder Alexandria Summit

Dean A. Shigenaga

James H. Richardson

Senior Management Consultant & Director

Founder & CEO

Larry J. Diamond

Senior Vice President

John J. Cox

Avidity Biosciences is a biotechnology company that develops oligonucleotide-based therapies for its patients.

Intel designs, manufactures and sells computer components and related products for business and consumer markets.

IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.

C2i Genomics provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations.

MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases.

Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies.

Integrated Diagnostics develops tools to help physicians diagnose complex diseases with a non-invasive blood test.

Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.

Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.

Private Equity Firms with Investments in North Carolina

Late Stage Venture Investors Female Founded Private Equity Firms

California Companies that Exited (Top 10K)

Greater Los Angeles Area Companies With More Than 100 Employees (Top 10K)

Alexandria Real Estate Equities is a real estate company. They offer engineering, asset management, laboratory operations, life science, construction, planning, health and environment, safety, project management, finance, collaboration, accounting, communications and public relations, events, venture investment, and sustainability.

Post-IPO Debt - Alexandria Real Estate Equities

Post-IPO Equity - Alexandria Real Estate Equities

Pasadena

California

United States

North America

Alexandria Real Estate Equities

Alexandria Real Estate Equities, Inc. Announces Long-Term 258,581 RSF Lease With Longstanding Tenant Vaxcyte, Inc. at the Alexandria Center for Life Science - San Carlos Mega Campus

Alexandria Real Estate Equities, Inc. Enables the Discovery, Development and Delivery of New Innovative Medicines That Are Key to Addressing Significant Unmet Medical Need

Alexandria Real Estate Equities declares $1.30 dividend

Alexandria Real Estate just downgraded at Jefferies, here's why

Alexandria Real Estate Equities cut to Neutral at BofA amid cautious leasing view

Alexandria Real Estate just downgraded at Evercore ISI, here's why

Alexandria Real Estate Equities' existing tenant executes new 10-year lease

Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.30 per Common Share for 2Q24, an Increase of 3 ...

Cloudflare CDN

Microsoft Outlook

GlobalSign

Google Analytics

jQuery

Bootstrap

Valimail

Alexandria Real Estate Equities owns Alexandria

Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500<sup>®</sup> urban office real estate investment trust ("REIT"), is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, technology, and agtech campuses in AAA innovation cluster locations, with a total market capitalization of $31.9 billion as of December 31, 2020, and an asset base in North America of 49.7 million square feet ("SF"). The asset base in North America includes 31.9 million RSF of operating properties and 3.3 million RSF of Class A properties undergoing construction, 7.1 million RSF of near-term and intermediate-term development and redevelopment projects, and 7.4 million SF of future development projects. Founded in 1994, Alexandria pioneered this niche and has since established a significant market presence in key locations, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, technology, and agtech campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, technology, and agtech companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.

Alexandria Real Estate Equities, Inc.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 21, 2024 9:14 PM	581e16a8
public peers	general
news daily refresh	general	Dec 4, 2024 2:16 PM	eb096918
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 21, 2024 9:14 PM	ea927511
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	0fc07575
crunchbase profile	general	Nov 25, 2024 11:40 AM	a6835bf3
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 2:16 PM	7b8cd385
peers	general
news basic	general	Dec 4, 2024 2:13 PM	82a9787d
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:ARE

Alexandria

Last Close

105.89

22/11 21:00

Market Cap

20.45B

Beta: -

Volume Today

1.31M

Avg: -